The early asthmatic response is associated with glycolysis, calcium binding and mitochondria activity as revealed by proteomic analysis in rats by Xu, Yu-Dong et al.
RESEARCH Open Access
The early asthmatic response is associated with
glycolysis, calcium binding and mitochondria
activity as revealed by proteomic analysis in rats
Yu-Dong Xu
1, Jian-Mei Cui
1, Yu Wang
2, Lei-Miao Yin
2, Chang-Ke Gao
1, Yan-Yan Liu
2, Yong-Qing Yang
1*
Abstract
Background: The inhalation of allergens by allergic asthmatics results in the early asthmatic response (EAR), which
is characterized by acute airway obstruction beginning within a few minutes. The EAR is the earliest indicator of
the pathological progression of allergic asthma. Because the molecular mechanism underlying the EAR is not fully
defined, this study will contribute to a better understanding of asthma.
Methods: In order to gain insight into the molecular basis of the EAR, we examined changes in protein expression
patterns in the lung tissue of asthmatic rats during the EAR using 2-DE/MS-based proteomic techniques.
Bioinformatic analysis of the proteomic data was then performed using PPI Spider and KEGG Spider to investigate
the underlying molecular mechanism.
Results: In total, 44 differentially expressed protein spots were detected in the 2-DE gels. Of these 44 protein
spots, 42 corresponded to 36 unique proteins successfully identified using mass spectrometry. During subsequent
bioinformatic analysis, the gene ontology classification, the protein-protein interaction networking and the
biological pathway exploration demonstrated that the identified proteins were mainly involved in glycolysis,
calcium binding and mitochondrial activity. Using western blot and semi-quantitative RT-PCR, we confirmed the
changes in expression of five selected proteins, which further supports our proteomic and bioinformatic analyses.
Conclusions: Our results reveal that the allergen-induced EAR in asthmatic rats is associated with glycolysis,
calcium binding and mitochondrial activity, which could establish a functional network in which calcium binding
may play a central role in promoting the progression of asthma.
Background
Asthma is a common yet complex disorder that affects
the airways of an estimated 300 million people of all
ages. As a widespread disease, asthma places heavy eco-
nomic burdens on both individuals and society [1].
Despite advances in understanding the pathogenesis of
asthma and the development of new anti-asthma thera-
pies, the prevalence and morbidity and mortality rates
of the disease have continuously increased worldwide
over the past two decades [2]. While the currently avail-
able anti-inflammatory and muscle-relaxing drugs are
effective in controlling the clinical symptoms, they do
not prevent the natural course of asthma [3]. A plausible
explanation for this failure is that different biological
mechanisms mediate the progression of asthma and
asthma symptoms, and unlike the symptoms, asthma
progression is insensitive to certain therapies [4]. There-
fore, it is necessary to further understand the molecular
mechanisms underlying asthma progression to develop
new, curative asthma drugs.
The inhalation of allergens by patients with allergic
asthma results in the early asthmatic response (EAR).
The EAR is characterized by an acute airway obstruction
that develops within a few minutes and generally
resolves within 1 to 2 h. This is usually followed by the
late asthmatic response [5]. As the early phase of the
natural course of asthma [4], the EAR is important for
the early recognition and treatment of this disease and
should receive more attention. Over the past two dec-
ades, several animal models that develop the EAR have
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observed 2 to 5 min after provocation in ovalbumin
(OVA)-sensitized rats challenged with OVA [8]. More-
over, the pathogenesis of the EAR has been studied by
measuring physiologic parameters, variations in serum
constituents and by the effect of pretreatment with var-
ious drugs [5]. Previous evidence has demonstrated that
the EAR can be associated with inflammatory mediators
secreted by pulmonary mast cells in an IgE-dependent
process, and following the activation of specific recep-
tors, these inflammatory mediators have spasmogenic
effects that result in abnormal airway smooth muscle
(ASM) contraction [5,9]. These findings have expanded
our understanding of the EAR at different levels. How-
ever, the molecular mechanism underlying the EAR
remains largely unknown. To gain insight into the pro-
tein basis of the EAR, a global protein profiling study is
urgently needed.
An increasing numbers of proteomics-based asthma
studies have been published in recent years, providing
useful information about the disease. More importantly,
these studies have identified several candidate proteins
or novel biomarkers that show an association with the
asthma phenotype (an elevated IgE level, bronchial
hyperresponsiveness and atopy) [10]. While these find-
ings have furthered our understanding of asthma pro-
gression, the present challenge is to understand the
natural course of asthma, including the EAR, and to
build a functional model to explain the underlying
molecular mechanisms of the disease. The primary pur-
pose of this study was to investigate the protein expres-
sion patterns in the OVA-induced EAR using proteomic
techniques and to elucidate the molecular basis of the
EAR.
Methods
Animals and sensitization protocol
Pathogen-free, male Sprague-Dawley (SD) rats (4 weeks
old, 110-130 g; SLAC Laboratory Animal Co., Shanghai,
China) raised in a pathogen-free rodent facility and pro-
v i d e dw i t hf o o da n dw a t e rad libitum were randomly
divided into two groups– control rats (n = 15) and asth-
matic rats (n = 14). The rats were kept in animal facil-
ities approved by the Shanghai Committee for the
Accreditation of Laboratory Animals for at least 1 week
before the experiments began. The animal experiments
conformed to the regulations set forth by the State
Science and Technology Commission.
The rats were sensitized and challenged with OVA
(grade V, Sigma, Taufkirchen, Germany) according to
the protocol described previously [8]. Briefly, on day 0,
rats were intraperitoneally injected with 1 mg of OVA
precipitated with 10 mg of aluminum hydroxide gel in
1 ml saline. On day 14, allergic rats were anaesthetized
with 1% sodium pentobarbitone (wt/vol) at a dose of 50
mg/kg by intraperitoneal injection and then challenged
with 1 ml/kg of 5% OVA in saline (5 mg/kg) by injec-
tion into the external jugular vein over 10 s. The control
rats received the same treatment schedule but were sen-
sitized and challenged with saline instead of OVA.
Measurement of respiratory function
The technique for the invasive respiratory function mea-
s u r e m e n t su s e di nt h i ss t u d yh a sb e e nd e s c r i b e dp r e -
viously [11]. Briefly, a rat was placed in a supine
position and warmed with an incandescent lamp after
anaesthesia. At the upper part of the trachea, a T-shape
incision was made and a T-shape cannula, which was
directly attached to a heater-controlled pneumotacho-
graph (Fleisch model 000, Hans Rudolph, USA), was
gently inserted into the trachea. Tidal flow was deter-
mined by a pneumotachograph connected to a differen-
tial pressure transducer (AutoTran, model 600D-011,
± 2 cmH2O). To measure the transpulmonary pressure,
a water-filled PE-90 tube was inserted into the esopha-
gus to the level of the mid-thorax (lower one-third of
the esophagus) and coupled to a pressure transducer
(PT14MX, Jialong Teaching Equipment, Shanghai). The
pneumotachograph tidal flow signal was integrated with
respect to time to obtain the tidal volume. The pulmon-
ary resistance (RL) and dynamic compliance (Cdyn)
were calculated over a complete respiratory cycle using
an integration method over flows, volumes and pres-
sures and were continuously recorded with software
(Shanghai Medical College, Fudan University) for phy-
siology experiments. The respiratory parameters were
averaged in 60-s segments, and the maximum RL, mini-
mum Cdyn and change of respiratory rate (RR) values
Figure 1 Protocol and measurements for the rat model of
allergic asthma. Male SD rats were sensitized intraperitoneally at
day 0 with 1 mg of OVA precipitated with 10 mg of aluminum
hydroxide gel in 1 ml saline. On day 14, rats were anaesthetized
with 1% sodium pentobarbitone (wt/vol) at a dose of 50 mg/kg
and challenged with 1 ml/kg of 5% OVA in normal saline (5 mg/kg)
by injection into the external jugular vein over 10 s. The pulmonary
resistance (RL), dynamic compliance (Cdyn) and respiratory rate (RR)
were recorded for 10 min before challenge as the baseline values
and then immediately measured for another 10 min after the
challenge. The changes in the RL, Cdyn and RR were calculated as
the differential values subtracted from the corresponding baseline
values. The rats were euthanized immediately after the
measurements were taken. Control rats were sensitized and
challenged with saline instead of OVA.
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subtracted from the corresponding baseline value (Fig-
ure 1). Following the respiratory function measurements,
the rats were euthanized. Lung tissue was excised imme-
diately, dissected from surrounding tissue in ice-cold
saline and then immediately frozen in liquid nitrogen.
Sample preparation
Proteins were extracted from each lung tissue sample
using the ReadyPrep Sequential Extraction Kit (Bio-Rad,
Hercules, CA) with the following additions to Reagent 1
added just prior to use: PMSF (1 mM), DNase (RNase-
free; 20 μg/ml) and RNase (5 μg/ml). The protein con-
centrations were determined using a modified Bradford
assay. For the 2-DE analysis, the protein extracts from
each animal in a group were pooled equally according
to the protein concentration and stored at -80°C until
use.
Two-dimensional gel electrophoresis (2-DE) and image
analysis
A fixed amount of protein (100 μg) was loaded onto 17-
cm IPG strips with a linear separation range of pH 3-10
(Bio-Rad, Hercules, CA). Using a Protean IEF Cell (Bio-
Rad), the first-dimensional isoelectric focusing (IEF) was
performed following the protocol provided by Bio-Rad
Laboratories. After equilibration in a buffer (50 mM
Tris-HCl pH 8.8, 6 M urea, 20% glycerol and 2% SDS)
supplemented with 2% DTT for 15 min and a second
incubation in this buffer supplemented with 2.5% iodoa-
cetamide for another 15 min, a Protean II XL cell
(Bio-Rad) with a polyacrylamide gel was used for the
second-dimensional separation. The proteins in the gel
were visualized following silver staining and scanned
with a GS-800 densitometer (Bio-Rad). The differentially
expressed proteins were detected using PDQuest soft-
ware version 7.1 (Bio-Rad). Only those spots with at
least a threefold change in intensity (p < 0.05, t-test)
were considered differentially expressed.
Protein identification
Proteins with significant changes in expression were
excised from the gels, washed, dehydrated and digested
with 12.5 ng/ml trypsin in 0.1 M NH4HCO3.L i q u i d -
chromatography electrospray-ionization tandem mass
spectrometry (LC-ESI-MS/MS) analysis was conducted
using a Finnigan LTQ mass spectrometer (Thermo-
Quest, San Jose, CA) coupled with a Surveyor HPLC
system (ThermoQuest). Protein identification using the
raw MS/MS data was performed with the SEQUEST
software (Thermo Finnigan) by searching against the
Swiss-Prot rat protein database. The identification
results were filtered based on the Xcorr (1+ ≥ 1.9, 2+ ≥
2.2, 3+ ≥ 3.75) and the DeltCn (≥ 0.1).
Bioinformatic analysis
To better understand the key regulated biological pro-
cesses occurring during the EAR, bioinformatic analysis
on the identified proteins, including the gene ontology
(GO) classification, the protein-protein interaction (PPI)
networking and the biological pathway exploration, were
carried out using PPI Spider [12] and KEGG (Kyoto
Encyclopedia of Genes and Genomes) Spider [13],
which are two freely available web-based tools for the
interpretation of experimentally derived protein lists in
the context of a global PPI network and a metabolic
network, respectively. A dataset containing the standard
gene symbols of the identified proteins was uploaded.
The significantly enriched GO classes (or terms), PPI
networks and biological pathways were determined with
the default parameter settings.
Western blot
The same protein samples used for the 2-DE were ana-
lyzed, and the polyvinylidene fluoride membranes were
blocked overnight in a PBS-Tween buffer with 5% non-
fat milk. The membranes were then probed using anti-
bodies specific for ERp29 (endoplasmic reticulum
protein ERp29), RhoGDI2 (Rho, GDP dissociation inhi-
bitor beta), S100A8 or b-actin in the blocking buffer.
The staining was visualized using ECL reagents (Beyo-
time, Haimen, China). The densitometric evaluation was
carried out using Quantity One software version 4.6
(Bio-Rad), and the relative quantity of an individual pro-
tein is expressed as the ratio of the gray scale respective
to that of b-actin.
Semi-quantitative RT-PCR
RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA) and reverse transcribed using the Rever-
tAid First Strand cDNA Synthesis Kit (MBI Fermentas,
Vilnius, Lithuania). PCR amplification was conducted
using the TaKaRa RNA PCR Kit (TaKaRa, Dalian,
China). The primers used were specific for S100A8,
S100A11, VDAC1 (voltage-dependent anion channel 1)
or b-actin (see additional file 1). The PCR products
were resolved by agarose gel electrophoresis and ana-
lyzed using Quantity One software (Bio-Rad). The rela-
tive mRNA level of each individual gene is presented as
the expression ratio with respect to the housekeeping
gene b-actin.
Statistical analysis
Student’s t-test was performed to evaluate the differ-
ences between the control and asthmatic group when
the data were normally distributed, while the Mann-
Whitney test was used when the data were not normally
distributed. The differences among continuous data in
each group obtained from the respiratory function
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test. The statistical analysis for PPI Spider and KEGG
Spider was performed using the Monte Carlo simulation
procedure. A p value less than 0.05 was considered sta-
tistically significant.
Results
Respiratory function measurement following OVA
challenge
The OVA challenge in sensitized rats induced a signifi-
cant increase in the RL and, simultaneously, significant
decreases in the Cdyn and RR compared with control
rats. These alterations indicated an OVA-induced EAR.
The most prominent change in asthmatic rats was in
the RL with a maximum increase of 0.110 ± 0.115 kPa/
ml/s (mean ± SD, p < 0.01, compared with the controls)
2 min after provocation (Figure 2). When compared
with controls, the Cdyn showed a maximum decrease at
3 min, and the RR showed a maximum decrease at 2
min (data not shown).
Proteomic analysis
The protein in the sample from each group was mea-
sured at least three times and verified to ensure that the
same protein patterns were obtained. In general, we
detected approximately 550-650 protein spots in each 2-
DE gel and observed a high rate of overlap (>90%) in
the parallel gels. In total, 44 protein spots showed con-
sistently differential expression between the asthmatic
group and the control in all three parallel experiments,
with 25 down-regulated spots and 19 up-regulated spots
(Figure 3A). After identification via mass spectrometry,
42 protein spots corresponding to 36 unique proteins
were successfully identified. Of the unique proteins, 21
were down-regulated and 16 were up-regulated in the
asthmatic rats (Table 1, Figure 3C). For the tubulin
alpha-1A chain, both up- and down-regulated expres-
sion patterns were observed, possibly reflecting differen-
tial post-translational modification of the same protein.
Bioinformatic analysis
The gene ontology (GO) provides three structured terms
to describe gene products: (i) the biological process to
which a gene product contributes; (ii) the molecular
function that describes the biochemical activities of the
gene product; and (iii) the cellular component, which
refers to the subcellular location where a gene product
is active and occurs [14]. In this study, the GO classifi-
cation was performed to identify the most important
GO classes (or terms) (p < 0.05, Monte Carlo simulation
procedure) of the input proteins (Figure 4, additional file
2). “Glycolysis” was a significantly enriched GO class of
biological process category involving six proteins, which
indicates a possible role for glycolysis during the EAR.
Among the enriched GO classes of molecular function
category, “calcium ion binding,” which involved five pro-
teins, was the most attractive given the potential role of
Ca
2+ and Ca
2+ homeostasis in airway reactivity and
asthma. In the cellular component category, seven pro-
teins were classified into the GO class “mitochondrion,”
which is probably due to the mitochondrial activation
during the EAR.
A protein-protein interaction (PPI) network created by
PPI Spider covered 16 identified proteins (Figure 5A).
Notably, ten proteins were connected by the intermedi-
ate protein GLUT4 (solute carrier family 2 [facilitated
glucose transporter], member 4), which promotes the
transport of glucose from the blood to target tissues
[15]. The pathway network constructed by KEGG Spider
covered eight identified proteins, and a total of six pro-
teins were involved in the “glycolysis” pathway constitut-
ing the key nodes of this network (Figure 5B). The
inferred in silico networks further suggest that glucose
metabolism, especially glycolysis, is involved in the
pathogenesis of the EAR.
Western blot analysis of RhoGDI2, ERp29 and S100A8
To verify the 2-DE findings, we further examined the
expression of RhoGDI2, ERp29 and S100A8 using wes-
tern blots. Compared with the controls, the expression
levels of RhoGDI2 and S100A8 were significantly
increased (p <0 . 0 1a n dp < 0.05, respectively) in the
asthmatic rats, whereas the expression of ERp29 was
significantly decreased (p < 0.01) in the asthmatic rats
(Figure 6). These expression patterns were consistent
with the patterns detected in the 2-DE analysis. These
results confirm the reliability of this comparative proteo-
mic study.
mRNA Level of S100A8, S100A11 and VDAC1
The mRNA level of S100A8 and S100A11 was low in
the control group, and this expression was significantly
higher in the asthmatic group (both p < 0.01, Figure 7).
These results not only demonstrate the up-regulation of
S100A8 and S100A11 at the mRNA level, but also sug-
gest enhanced Ca
2+ binding during the EAR.
To assess whether the mitochondrial activity was
increased during the EAR, the mRNA expression pattern of
VDAC1, an outer membrane mitochondrial protein, was
investigated using RT-PCR. As seen in Figure 7, the mRNA
level of VDAC1 was significantly up-regulated in the lungs
of asthmatic rats compared to the controls (p <0 . 0 1 ) .
Discussion
The EAR is the early phase of the natural course of aller-
gic asthma and is important for the early recognition and
treatment of this disease. Although a number of proteo-
mic studies have identified several candidate proteins
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studies of the EAR have been reported [10]. In this study,
we compared the protein profiles of the lung tissue
extracted from rats with an OVA-induced EAR with
those of the controls using 2-DE/MS-based proteomic
analysis. We identified 44 differentially expressed protein
spots corresponding to 36 unique proteins. These pro-
teins reflected a protein profile that changed during the
disease process, which included sensitization, allergen
challenge and the subsequent EAR. A functional analysis
of these changed proteins revealed some possible key
molecular mechanisms underlying the EAR.
Glycolysis during the EAR
Glycolysis is a fundamental system for energy metabo-
lism in most organisms, and glycolytic enzymes are pre-
sent in all mammalian cells and tissues. Over the past
few decades, several lines of evidence have indicated
that the EAR-associated events, including hypoxia and
ASM contraction, could affect and be affected by energy
and glucose metabolism [16-18]. Using a proteomic
approach, our study demonstrates that the EAR is clo-
sely associated with glycolysis.
The GO analysis demonstrated that six of the identi-
fied proteins are important in glycolysis (Figure 4).
Figure 2 Changes in the pulmonary resistance after challenge. Box plots of the pulmonary resistance (RL) within 10 min after challenge in
asthmatic rats (n = 14, sensitized and challenged with OVA) and controls (n = 15, sensitized and challenged with normal saline). The RL values
are expressed as differential values subtracted from the corresponding baseline values (Figure 1). Mild outliers (○) are cases with values between
1.5 and 3 box lengths from the upper or lower edge of the box. Extreme outliers (+) are cases with values more than 3 box lengths from the
upper or lower edge of the box. As measured using the Kruskal-Wallis test, the differences in the RL at each time point in the asthmatic group,
but not in the control group, were significant (p < 0.01). Significant differences in the RL were observed between the two groups at 1-6 min (* p
< 0.05, ** p < 0.01, Mann-Whitney test) with a maximum increase in asthmatic rats observed 2 min after challenge.
Xu et al. Respiratory Research 2010, 11:107
http://respiratory-research.com/content/11/1/107
Page 5 of 11Among them, phosphoglycerate kinase 1 is well known
as the seventh enzyme of the glycolytic pathway, which
catalyzes the reversible conversion of 1,3-diphosphogly-
cerate to 3-phosphoglyceric acid and a single ATP mole-
cule. It has been recently reported that phosphoglycerate
kinase 1 can enhance the glycolytic capacity of an organ
and support the maintenance of cellular energetics in
wood frogs with hypoxia [19]. Pyruvate kinase catalyzes
the penultimate step in glycolysis, where it transfers
phosphate from phosphoenolpyruvate to ADP, leading
to the formation of ATP and pyruvate. The energy
regeneration by pyruvate kinase is independent of the
oxygen supply, which allows for the survival of cells
under hypoxic conditions [20]. Glyceraldehyde-3-
phosphate dehydrogenase is another essential glycolytic
enzyme expressed in all prokaryotic and eukaryotic
organisms. Its role is to convert glyceraldehyde-3-
phosphate to 1,3-diphosphoglycerate during glycolysis.
The significantly higher expression level of all of the
above proteins in asthmatic rats suggests the up-regula-
tion of glycolysis during the EAR. Two other glycolytic
enzymes, beta-enolase and phosphoglycerate mutase,
both found in the lung tissue proteome, are also rate-
controlling enzymes in glycolysis. Their decreased
expression could regulate the rate of glycolysis as well
as the ATP-dependent reactions involved in the EAR.
Our proteomic analysis indicates that glycolysis is a key
regulatory biological process in the pathogenesis of the
EAR. These glycolytic enzymes may facilitate the anae-
robic production of ATP to meet the increasing cellular
energy demands during ASM contraction in the hypoxic
conditions induced by airway obstruction. It should be
noted, however, that glycolysis alone may not meet the
needs of the contractions because it only provides two
ATP molecules from every glucose molecule while oxi-
dative phosphorylation and lactic acid may be more effi-
cient energy-supplying processes under hypoxic
conditions. However, our results confirm the importance
of energy metabolism and energy balance during the
EAR, which could provide new clues for the further
study of asthma.
Additionally, a recent review reported that some gly-
colytic enzymes are complicated, multifaceted proteins
rather than simple components of the glycolytic pathway
[21]. These enzymes also possessed non-glycolytic func-
tions involved in transcriptional regulation, the
Figure 3 Protein expression profiles in lung and asthmatic lung tissue. (A) Representative 2-D gel images of proteins isolated from normal
control (left) and asthmatic rats (right). Total protein extracts were separated on 17-cm linear IPG strips (pH 3-10) in the first dimension followed
by 12% SDS-PAGE in the second dimension and visualized by silver staining. (Left) The 25 down-regulated protein spots in asthmatic rats are
marked with arrows. (Right) The 19 up-regulated protein spots in asthmatic rats are marked with arrows. The numbers correspond to the spot
identification numbers listed in Table 1. The molecular weight standards and the pH range are shown at the left and the bottom of the gels,
respectively. (B) Cropped 2-DE gel images of the S100A8 and RhoGDI2 protein spots. The selected area was symmetrically boxed, and the arrows
indicate each protein spot or its theoretical location. (C) The expression profile of 28 most significantly changed proteins that were detected
more than three times. The upper portion shows the 17 proteins down-regulated in asthmatic lung tissue, and the lower portion shows the 11
proteins that were up-regulated. Each spot volume was quantified from the intensity of the spots using PDQuest software. The bars represent
the mean ± SD from three replicated 2-DE gels. The information for each altered spot is reported in Table 1.
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Spot* Protein Name Gene
Symbol
Swiss-Prot/RefSeq
accession No.
Theoretical Mr
(kD)/pI
†
Pept./% Seq.
Cov
‡
Down-regulated in Asthmatic rats
1 Uteroglobin precursor Scgb1a1 P17559 10.4/4.9 7/25.00%
2 Alpha-1-antiproteinase precursor Serpina1 P17475 46.1/5.7 6/11.68%
3 Tubulin alpha-1A chain Tuba1a P68370 50.1/4.9 6/9.31%
4 Gamma-enolase Eno2 P07323 47.0/7.0 2/5.07%
5 Heat shock cognate 71 kDa protein Hspa8 P63018 70.8/5.4 3/4.18%
6 Calreticulin Calr P18418 48.0/4.3 49/36.06%
7 Phosphatidylethanolamine-binding protein 1 Pebp1 P31044 20.8/5.5 9/25.13%
8 predicted Coactosin-like 1 Cotl1 B0BNA5 15.9/5.3 6/27.46%
9 Beta-enolase Eno3 P15429 47.0/7.0 2/5.07%
10 Endoplasmic reticulum protein ERp29 precursor Erp29 P52555 28.6/6.2 71/48.85%
11 protein disulfide isomerase associated 6 Pdia6 Q63081 48.8/5.0 20/26.07%
12 Beta-enolase Eno3 P15429 47.0/7.0 3/5.07%
13 N-acetylneuraminic acid synthase Nans B1WC26 40.0/6.4 9/17.83%
14 Bifunctional purine biosynthesis protein PURH Atic O35567 64.2/6.7 5/6.42%
15 Creatine kinase B-type Ckb P07335 42.7/5.4 2/4.46%
16 Isoform 1 of Fibrinogen beta chain precursor Fgb P14480-1 54.2/7.9 55/45.30%
17 Carbonic anhydrase 2 Ca2 P27139 29.1/6.9 32/50.38%
18 22 kDa protein –– – 5/22.12%
19 Heat shock cognate 71 kDa protein Hspa8 P63018 70.8/5.4 19/18.89%
20 Advanced glycosylation end product-specific receptor
precursor
Ager Q63495 42.7/5.8 25/23.38%
21 similar to proteasome 26 S ATPase subunit 6 Psmc6 Q32PW9 45.8/7.6 17/27.79%
22 22 kDa protein –– – 7/25.00%
23 Cofilin-1 Cfl1 P45592 18.5/8.2 95/78.92%
24 Heat shock-related 70 kDa protein 2 Hspa2 P14659 69.6/5.5 6/4.27%
25 Phosphoglycerate mutase 1 Pgam1 P25113 28.8/6.7 11/16.93%
Up-regulated in Asthmatic rats
26 Myotrophin Mtpn P62775 12.9/5.3 6/25.42%
27 Anionic trypsin-1 precursor Prss1 P00762 26.0/4.7 4/8.13%
28 Isoform M1 of Pyruvate kinase isozymes M1/M2 Pkm2 P11980 58.0/6.6 40/25.52%
29 Protein S100-A8 S100a8 P50115 10.2/5.7 6/56.18%
30 Protein S100-A8 S100a8 P50115 10.2/5.7 26/41.57%
31 Sodium/potassium-transporting ATPase subunit alpha-1
precursor
Atp1a1 P06685 11.3/5.3 16/13.29%
32 similar to destrin LOC296197 XP_215862 18.5/7.5 11/27.88%
33 Glutathione S-transferase Mu 2 Gstm2 P08010 25.7/6.9 18/38.99%
34 Tubulin alpha-1A chain Tuba1a P68370 50.1/4.9 11/13.53%
35 Rho, GDP dissociation inhibitor (GDI) beta Arhgdib Q5M860 22.9/5.0 4/21.00%
36 Serum albumin precursor Alb P02770 68.7/6.1 194/60.36%
37 Phosphoglycerate kinase 1 Pgk1 P16617 44.5/8.0 9/29.50%
38 Actin, alpha skeletal muscle Acta1 P68136 42.0/5.2 8/11.94%
39 Serum albumin precursor Alb P02770 68.7/6.1 7/6.58%
40 ATP synthase subunit alpha, mitochondrial precursor Atp5a1 P15999 59.8/6.2 53/22.24%
41 Glyceraldehyde-3-phosphate dehydrogenase Gapdh P04797 35.8/8.1 5/12.31%
42 Glyceraldehyde-3-phosphate dehydrogenase Gapdh P04797 35.8/8.1 17/29.73%
43 S100a11 S100a11 Q6B345 11.1/5.6 3/26.5%
44 similar to Ras suppressor protein 1 Rsu1 XP_001057090 31.5/8.5 4/10.83%
The proteins were identified using LC-ESI-MS/MS following in-gel tryptic digest. Proteins are designated with their protein name, standard gene symbol and
Swiss-Prot/NCBI RefSeq accession number.
* The spot number from 2-D gel analysis (Figure 3).
† The theoretical molecular mass (Mr) and isoelectric point (pI) of the identified protein.
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sis. With these multifaceted functions, glycolytic
e n z y m e sc o u l dp l a yar o l ei nt h eh y p e r p l a s i ao rh y p e r -
trophy of ASM cells in asthma disease. Therefore, the
identification of differentially expressed glycolytic pro-
teins in the lung tissue proteome also suggests that air-
way remolding may develop during the EAR.
Calcium binding during the EAR
Calcium binding is a key initiating process for the EAR
because the binding of Ca
2+ to calmodulin to form the
Ca
2+/calmodulin complex results in the activation of
myosin light-chain kinase, which, in turn, mediates
ASM contraction [22]. In this study, we observed the
increased expression of Ca
2+-binding proteins (CaBPs)
in the 2-DE analysis and further verified the increased
expression of S100A8 and S100A11 using western blot
and RT-PCR, respectively. In our previous study, we
also reported the increased mRNA level of another
CaBP, S100A9, through the serial analysis of gene
expression during the EAR [8].
Calcium is a central player that mediates various
pathophysiological reactions through binding with
CaBPs. Cells contain classes of CaBPs that regulate the
level of cytosolic Ca
2+ and transduce intracellular Ca
2
+-mediated signals. S100 proteins, which are highly
homologous, low-molecular weight (10-12 kDa), acidic
proteins, constitute one of the CaBP families. They are
believed to be involved in the regulation of Ca
2+ home-
ostasis, smooth muscle contraction and other cellular
processes through their binding to Ca
2+ and interactions
with various effector proteins [23]. S100 proteins have
received increased attention in the study of asthma due
Figure 4 Gene Ontology (GO) classification. GO classification for
all of the identified proteins based on three domains: biological
process, molecular function and cellular component. The number of
proteins enriched in each GO class is shown at the right side of the
bars.
Figure 5 The in silico networks inferred by PPI Spider and KEGG Spider. The proteins identified in the proteomic study are marked by
rectangles, and red nodes represent the proteins involved in glycolysis. (A) The PPI Spider network model covers 16 identified proteins. The
intermediate proteins not detected in the proteomic study are marked by circles and the corresponding Entrez gene IDs: 25139, GLUT4 (solute
carrier family 2 [facilitated glucose transporter], member 4); 24413, NR3C1 (glucocorticoid receptor); 58945, DYNLL1 (dynein light chain 1,
cytoplasmic); and 117282, hnRNP K (heterogeneous nuclear ribonucleoprotein K). (B) The KEGG Spider network model covers eight identified
proteins. The intermediate proteins not detected in the proteomic study are marked by triangles and the corresponding Entrez gene ID: 85260,
ENTPD6 (ectonucleoside triphosphate diphosphohydrolase 6). The chemical compounds involved are marked with circles.
Figure 6 Validation of the 2-DE proteomic data by western
blot analysis. (A) A representative western blot visualizing the
ERp29, RhoGDI2 and S100A8 expression levels. b-actin was used to
demonstrate equal loading. NC = normal control group (n = 15)
and AS = asthmatic group (n = 14). (B) The densitometric
quantification of individual protein is expressed as the fold change
compared to b-actin. The data are presented as the mean ± SD of
triplicate experiments, and similar results were seen in all
experiments. Statistical comparisons were made using Student’s t-
test. *p < 0.05, **p < 0.01 comparing the asthmatic group with the
control group. The expression pattern of these proteins is in
agreement with the 2-DE results.
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S100A8 and A9, also known as calgranulins, have been
shown to play a role in the initiation and regulation of
chronic and acute inflammatory diseases, including
asthma [24,25]. A study examining human asthmatic
bronchoalveolar lavage fluid showed that elevated levels
of S100A8 and S100A9 were strongly linked to allergic
inflammation [26]. Moreover, the inhibition of S100A8
and S100A9 could reduce the migration of inflammatory
cells into the lungs in a mouse model of asthma [27].
Recent evidence has also demonstrated that S100A8 and
S100A9 are involved in a novel pro-inflammatory signal-
ing pathway in which they contribute to the activation
of central cellular pathways, including the p38 or p44/42
MAP kinases and NF-B signaling components, which
subsequently induce the expression of many pro-
inflammatory molecules [28,29]. In our studies, elevated
expression levels of S100A8 and S100A9 were found in
asthmatic rats, indicating that during the EAR, CaBPs
such as S100A8 and A9 could trigger the asthmatic
inflammatory response.
Calreticulin and protein disulfide-isomerase A6 are
endoplasmic reticulum-resident, luminal Ca
2+-buffering
chaperones involved in the storage of Ca
2+ and the reg-
ulation of the intracellular Ca
2+ concentration ([Ca
2+]i)
[30,31]. Their decreased expression levels suggest that
the release of Ca
2+ from the intracellular Ca
2+ stores
causes an elevation of the [Ca
2+]i in ASM cells. ERp29 is
a newly identified ER lumen-resident protein that lacks
Ca
2+ binding activities. In our study, decreased ERp29
expression was detected during the EAR, and this
change in expression was validated by western blot.
Although ERp29 cannot bind Ca
2+,i tm a yi n t e r a c tw i t h
Ca
2+-binding molecular chaperones on the membrane of
the mitochondrial sheath and thus may indirectly influ-
ence Ca
2+ transport [32]. S100A11 is a CaBP with an
intermediate expression level in lung tissue and plays a
key role in the regulation of enzymatic activity, cell
growth, apoptosis and inflammation [33]. In contrast to
the proteomic study of a chronic mouse asthma model
that demonstrated marked down-regulation of S100A11
[34], we observed an increased expression level of
S100A11 during the EAR. However, the precise role of
this protein in asthma remains unclear and needs
further investigation.
It has long been established that an increased [Ca
2+]i
might account for the heightened ASM contractility,
increased mucous gland secretion and elevated mast cell
mediator secretion rate observed in asthma [35]. Conse-
quently, agonist-induced Ca
2+ signaling and altered Ca
2+
homeostasis have been regarded as possible therapeutic
targets in the pathophysiology of asthma. It is highly
plausible that the inhibition of Ca
2+ mobilization into
ASM cells could effectively reverse acute airway obstruc-
tion. Based on the results presented in this study, Ca
2+
and its role in asthma should be examined in more
detail. Compared with Ca
2+ mobilization, the binding of
Ca
2+ and the downstream biological events induced by
the interaction between CaBPs and effector proteins
may play a more crucial role in the progression of
asthma. Further studies on Ca
2+ binding and its effects
will help determine whether CaBPs can be used as novel
drug targets for the treatment of asthma.
Mitochondrial activity during the EAR
Mitochondria have a critical role in ATP production and
are sometimes described as “cellular power plants” [36].
In addition to their bioenergetic function, mitochondria
have been increasingly recognized as key players in cel-
lular regulatory systems including Ca
2+ handling and
apoptosis, as well as numerous other catabolic and ana-
bolic pathways [37,38]. Accumulating clinical and
experimental evidence has suggested a possible role for
mitochondrial activity in the pathogenesis of asthma. In
asthmatic ASM cells, there was a higher basal energy
turnover due to the increased number and activity of
mitochondria [39]. Similarly, Ca
2+-dependent enhanced
mitochondrial biogenesis has been demonstrated in the
bronchial smooth muscle of asthmatic patients, and this
was causatively linked to airway remodeling [40].
In our study, seven of the identified proteins were
enriched in the GO class “mitochondrion” (Figure 4).
Among them was Atp5a1, which is a well-characterized
mitochondrial protein found in the mitochondrial inner
membrane [41]. It is well known that Atp5a1 is an
important, enzymatically active member of the F0-F1
mitochondrial ATP synthase (Complex V). This
Figure 7 Semi-quantitative RT-PCR analysis of the S100A8,
S100A11 and VDAC1 mRNA expression level. (A) Representative
RT-PCR visualizing the S100A8, S100A11 and VDAC1 mRNA
expression levels; b-actin was used as an internal control. NC =
normal control group (n = 15) and AS = asthmatic group (n = 14).
(B) The densitometric quantification of the mRNA level of the
individual genes is expressed as the fold change compared to b-
actin. The data are presented as the mean ± SD from triplicate
experiments, and similar results were seen in all experiments.
Statistical comparisons were made using Student’s t-test. *p < 0.05,
**p < 0.01 comparing the asthmatic group with the control group.
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drial electron transport chain necessary for the genera-
tion of ATP. The enhanced expression of Atp5a1
further illustrates the energetic adaptations in the ASM
with increased contractility during the EAR. Glyceralde-
hyde-3-phosphate dehydrogenase and pyruvate kinase
are also mitochondria-localized proteins that were up-
regulated in the lung proteome of asthmatic rats. Pre-
vious evidence has shown that these glycolytic enzymes
can be attached to the outside of mitochondria, where
they funnel pyruvate directly into the citric acid cycle in
response to cellular energy demands [42,43].
To further investigate whether these mitochondrial
proteins are linked to the relative mitochondrial abun-
dance, we examined the mRNA expression pattern of
VDAC1, a mitochondrial protein localized to the outer
mitochondrial membrane that is commonly used to
assess the mitochondrial mass and activity in a specific
sample [40]. The significantly up-regulated mRNA level
of VDAC1 in the asthmatic group further indicates the
elevated biological activity of mitochondria during the
EAR. Our findings suggest that mitochondria may repre-
sent a potential target for the treatment of asthma in the
early phase. Further studies are required to determine
the exact functional significance of mitochondria in
asthma and assess whether drugs interfering with mito-
chondrial activity can prevent and/or reverse asthma
progression.
In general, the contractility of ASM during the EAR
requires an elevation in the [Ca
2+]i.M i t o c h o n d r i ac a n
transiently store Ca
2+, and together with the ER, can
function as the main source of the Ca
2+ that is released
to increase the [Ca
2+]i [ 4 4 ] .I na d d i t i o nt oi n i t i a t i n g
ASM contraction by binding with calmodulin, the
increased [Ca
2+]i could facilitate the binding of Ca
2+ to
Ca
2+ signaling proteins, such as the S100 proteins. This
binding would, in turn, allow their interaction with a
wide spectrum of effector proteins to activate Ca
2+ sig-
naling pathways in ASM cells. Increased glycolysis and
mitochondrial activity during the EAR would ensure an
adequate energy supply necessary for ASM contraction,
Ca
2+ binding, transport and the transduction of Ca
2+
signaling under hypoxic conditions through an interac-
tive process. Taken together, a multifaceted picture
emerges from our proteomic study. It suggests key roles
for cellular energy adaptation and the propagation of
Ca
2+ signaling during the EAR in which Ca
2+ binding
m a yp l a yac e n t r a lr o l et op r o m o t et h ep r o g r e s s i o no f
asthma.
Conclusions
In this study, we used a 2-DE/MS-based proteomic
approach to examine the lung protein profile of
asthmatic rats during the EAR. A comparison of the
asthmatic rats with the normal controls revealed differ-
ences in the protein expression pattern that were high-
lighted by the gene ontology classification, the PPI
interaction networking and the biological pathway
exploration. Our results indicate that the allergen-
induced EAR is associated with glycolysis, Ca
2+ binding
and mitochondrial activity, which could establish a func-
tional network with Ca
2+ binding as the central player
to promote the progression of asthma. These findings
may provide new clues important for to the early recog-
nition and treatment of asthma.
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